D. B. van Wieren-de Wijer

Are there interactions between the Gly460Trp α-adducin gene variant and the use of diuretics?

O. Klungel, A. H. Maitland‐van der Zee, D. B. van Wieren-de Wijer, 2008, Personalized medicine.

Reasons for non‐response in observational pharmacogenetic research

B. Psaty, B. Stricker, C. V. van Duijn, 2009, Pharmacoepidemiology and drug safety.

Genetic variation in the renin—angiotensin system, use of renin—angiotensin system inhibitors and the risk of myocardial infarction

B. Psaty, B. Stricker, C. V. van Duijn, 2011, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Interaction between the Gly460Trp α-adducin gene variant and diuretics on the risk of myocardial infarction

B. Psaty, C. V. van Duijn, A. Kroon, 2009, Journal of hypertension.

Determinants of DNA yield and purity collected with buccal cell samples

C. V. van Duijn, A. Kroon, P. D. de Leeuw, 2009, European Journal of Epidemiology.

Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant

B. Stricker, C. V. van Duijn, A. Kroon, 2008, Pharmacogenetics and genomics.